Han G. Witjes

Oss, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.

An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.

Journal: Clinical and translational science
Published: September 04, 2025

Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema.

Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema.

Journal: Clinical and translational science
Published: June 12, 2025

Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.

Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.

Journal: CPT: pharmacometrics & systems pharmacology
Published: October 03, 2022

The QUILT study: quilting sutures in patients undergoing breast cancer surgery: a stepped wedge cluster randomized trial study.

The QUILT study: quilting sutures in patients undergoing breast cancer surgery: a stepped wedge cluster randomized trial study.

Journal: BMC cancer
Published: April 06, 2022

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions: Exposure-Response Analyses of a Pivotal Phase I/II Study.

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions: Exposure-Response Analyses of a Pivotal Phase I/II Study.

Journal: Clinical pharmacology and therapeutics
Published: December 23, 2021

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.

Journal: EBioMedicine
Published: July 20, 2021

Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia.

Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia.

Journal: AJOG global reports
Published: June 12, 2021

Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority.

Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority.

Journal: Clinical pharmacology and therapeutics
Published: April 18, 2019

Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study.

Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study.

Journal: Journal of clinical pharmacology
Published: March 27, 2019

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing.

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing.

Journal: CPT: pharmacometrics & systems pharmacology
Published: January 11, 2019

Operating characteristics of stepwise covariate selection in pharmacometric modeling.

Operating characteristics of stepwise covariate selection in pharmacometric modeling.

Journal: Journal of pharmacokinetics and pharmacodynamics
Published: October 14, 2018

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.

Journal: Journal of clinical pharmacology
Published: August 16, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026